<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Inherited <z:hpo ids='HP_0005528'>bone marrow failure</z:hpo> syndromes (BMFs) comprise at least one-fourth of children with <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo>, and perhaps up to 10% of adults </plain></SENT>
<SENT sid="1" pm="."><plain>The most common syndrome is Fanconi's <z:hpo ids='HP_0001903'>anemia</z:hpo> (FA), with more than 1,000 reported cases </plain></SENT>
<SENT sid="2" pm="."><plain>FA is <z:hpo ids='HP_0000007'>autosomal recessive</z:hpo>, with birth defects in approximately 75% of patients </plain></SENT>
<SENT sid="3" pm="."><plain>It is a DNA repair syndrome, diagnosed by finding chromosomal aberrations in cells treated with clastogenic agents </plain></SENT>
<SENT sid="4" pm="."><plain>The major problems in FA are, in order, <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo>, <z:hpo ids='HP_0001909'>leukemia</z:hpo>, and other <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>There are at least five complementation groups; the gene for Group C has been cloned </plain></SENT>
<SENT sid="6" pm="."><plain>Carrier identification and gene therapy are beginning in families at risk for FAC mutations </plain></SENT>
<SENT sid="7" pm="."><plain><z:mp ids='MP_0009563'>Dyskeratosis</z:mp> congenita (DC) is primarily <z:hpo ids='HP_0001417'>X-linked</z:hpo> (at Xq28), with <z:hpo ids='HP_0000007'>autosomal recessive</z:hpo> and dominant cases as well </plain></SENT>
<SENT sid="8" pm="."><plain>Patients classically have reticulated hyperpigmented skin, <z:hpo ids='HP_0008404'>dystrophic nails</z:hpo>, and mucous membrane <z:e sem="disease" ids="C0023531" disease_type="Neoplastic Process" abbrv="">leukoplakia</z:e>. approximately 50% develop <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo>, sometimes prior to the DC phenotype, and approximately 10% develop <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> </plain></SENT>
<SENT sid="9" pm="."><plain><z:e sem="disease" ids="C0272170" disease_type="Disease or Syndrome" abbrv="">Shwachman-Diamond syndrome</z:e> consists of <z:hpo ids='HP_0001738'>exocrine pancreatic insufficiency</z:hpo> with <z:hpo ids='HP_0001875'>neutropenia</z:hpo>; approximately 25% develop <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> and 5%-10% develop <z:hpo ids='HP_0001909'>leukemia</z:hpo> </plain></SENT>
<SENT sid="10" pm="."><plain><z:hpo ids='HP_0004859'>Amegakaryocytic thrombocytopenia</z:hpo> presents in infancy, and often evolves into <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> and/or <z:hpo ids='HP_0001909'>leukemia</z:hpo> </plain></SENT>
<SENT sid="11" pm="."><plain>Single cytopenias include Diamond-Blackfan <z:hpo ids='HP_0001903'>anemia</z:hpo> (<z:chebi fb="28" ids="35299">DBA</z:chebi>), which is inherited pure red cell <z:mpath ids='MPATH_58'>aplasia</z:mpath>; <z:hpo ids='HP_0005510'>transient erythroblastopenia</z:hpo> of childhood; <z:e sem="disease" ids="C0340970" disease_type="Disease or Syndrome" abbrv="">Kostmann's syndrome</z:e> (KS) or infantile genetic <z:mp ids='MP_0000334'>agranulocytosis</z:mp>, and <z:hpo ids='HP_0001873'>thrombocytopenia</z:hpo> with absent radii in which there is neonatal <z:hpo ids='HP_0001873'>thrombocytopenia</z:hpo> and absent radii </plain></SENT>
<SENT sid="12" pm="."><plain><z:chebi fb="28" ids="35299">DBA</z:chebi> and KS, particularly the latter treated with G-CSF, may develop <z:hpo ids='HP_0001909'>leukemia</z:hpo>, and <z:e sem="disease" ids="C0280100" disease_type="Neoplastic Process" abbrv="">solid tumors</z:e> have been reported in <z:chebi fb="28" ids="35299">DBA</z:chebi> </plain></SENT>
<SENT sid="13" pm="."><plain>Treatment for the various BMFs includes bone marrow transplantation, <z:chebi fb="5" ids="50113">androgens</z:chebi>, and hematopoietic cytokines such as G-CSF </plain></SENT>
<SENT sid="14" pm="."><plain>These inherited syndromes thus include various combinations of marrow failure and premalignancy </plain></SENT>
</text></document>